McKesson Corporation

NYSE:MCK Rapport sur les actions

Capitalisation boursière : US$64.9b

McKesson Gestion

Gestion contrôle des critères 3/4

Le PDG McKesson est Brian Tyler, nommé en Apr2019, a un mandat de 5.58 ans. La rémunération annuelle totale est $ 19.00M, composée du salaire de 7.8% et des bonus 92.2%, y compris les actions et options de la société. détient directement 0.061% des actions de la société, d'une valeur de $ 39.45M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.5 ans et 3.2 ans.

Informations clés

Brian Tyler

Directeur général

US$19.0m

Rémunération totale

Pourcentage du salaire du PDG7.8%
Durée du mandat du directeur général5.6yrs
Propriété du PDG0.06%
Durée moyenne d'occupation des postes de direction3.5yrs
Durée moyenne du mandat des membres du conseil d'administration3.2yrs

Mises à jour récentes de la gestion

Recent updates

McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff

Oct 09

McKesson: The Correction Is Not Over

Sep 10

McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

Aug 22
McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

McKesson Corporation: An Interesting Health Giant With A Hidden Gem

Jul 04

With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

May 09
With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Mar 14
Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

Feb 19

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Feb 16
McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

Jan 29
Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

Jan 19

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

Nov 20
If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Nov 08

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

Oct 30
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson: Still Trading For A Huge Discount

Sep 06

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Aug 21
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

Jul 27
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

Jun 28

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

May 23
Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Apr 17
Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Feb 22
Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

Feb 08

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12
McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

Analyse de la rémunération des PDG

Comment la rémunération de Brian Tyler a-t-elle évolué par rapport aux bénéfices de McKesson?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

US$3b

Mar 31 2024US$19mUS$1m

US$3b

Dec 31 2023n/an/a

US$3b

Sep 30 2023n/an/a

US$3b

Jun 30 2023n/an/a

US$4b

Mar 31 2023US$20mUS$1m

US$4b

Dec 31 2022n/an/a

US$3b

Sep 30 2022n/an/a

US$2b

Jun 30 2022n/an/a

US$1b

Mar 31 2022US$18mUS$1m

US$1b

Dec 31 2021n/an/a

US$1b

Sep 30 2021n/an/a

-US$5b

Jun 30 2021n/an/a

-US$4b

Mar 31 2021US$15mUS$1m

-US$5b

Dec 31 2020n/an/a

-US$4b

Sep 30 2020n/an/a

US$2b

Jun 30 2020n/an/a

US$922m

Mar 31 2020US$15mUS$1m

US$906m

Dec 31 2019n/an/a

-US$905m

Sep 30 2019n/an/a

-US$626m

Jun 30 2019n/an/a

US$601m

Mar 31 2019US$13mUS$929k

US$33m

Rémunération vs marché: La rémunération totale de Brian ($USD 19.00M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 12.87M ).

Rémunération et revenus: La rémunération de Brian a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Brian Tyler (57 yo)

5.6yrs

Titularisation

US$18,997,543

Compensation

Mr. Brian S. Tyler, Ph D., has been an Independent Director at Republic Services, Inc. since April 1, 2021. He served as Chairman of Supervisory Board at McKesson Europe AG since August 9, 2018 until 2022....


Équipe de direction

NomPositionTitularisationCompensationPropriété
Brian Tyler
CEO & Director5.6yrsUS$19.00m0.061%
$ 39.4m
Britt Vitalone
Executive VP & CFO6.8yrsUS$6.78m0.011%
$ 7.3m
Michele Lau
Executive VP & Chief Legal Officerless than a yearUS$8.81m0.00011%
$ 71.4k
LeAnn Smith
Executive VP & Chief Human Resources Officer1.9yrsUS$3.54m0.0016%
$ 1.0m
Thomas Rodgers
Executive VP and Chief Strategy & Business Development Officer4.4yrsUS$3.18m0.0020%
$ 1.3m
Napoleon Rutledge
Senior VP2.7yrspas de données0.0015%
$ 986.7k
Francisco Fraga
Executive VP1.1yrspas de donnéespas de données
Rachel Rodriguez
Vice President of Investor Relationsno datapas de donnéespas de données
Pete Slone
Senior Vice President of Corporate Public Affairs9.4yrspas de donnéespas de données
Kirk Kaminsky
President of The US Pharmaceutical & Specialty Solutions Business5.6yrspas de donnéespas de données
Paul Smith
Senior Vice President of Taxesno datapas de donnéespas de données
Kevin Emerson
Senior Vice President of Finance Operations2.7yrspas de donnéespas de données

3.5yrs

Durée moyenne de l'emploi

51.5yo

Âge moyen

Gestion expérimentée: L'équipe de direction de MCK est considérée comme expérimentée (ancienneté moyenne 3.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Brian Tyler
CEO & Director5.6yrsUS$19.00m0.061%
$ 39.4m
Donald Knauss
Independent Chairman of the Board10.1yrsUS$555.22k0.0016%
$ 1.0m
Maria Martinez
Independent Director5.1yrsUS$335.08k0.00027%
$ 175.3k
Dominic Caruso
Independent Director6.2yrsUS$336.21k0.00027%
$ 175.3k
Deborah Dunsire
Directorless than a yearpas de donnéespas de données
James Hinton
Independent Director2.8yrsUS$315.08k0%
$ 0
Webster Dunbar
Independent Director2.6yrsUS$315.08k0%
$ 0
Kathleen Wilson-Thompson
Independent Director2.8yrsUS$315.08k0%
$ 0
Richard Carmona
Independent Director3.2yrsUS$313.71k0%
$ 0
Kevin Ozan
Independent Directorless than a yearUS$139.34k0.000010%
$ 6.5k
Bradley Lerman
Independent Director6.6yrsUS$328.71k0%
$ 0

3.2yrs

Durée moyenne de l'emploi

66yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de MCK sont considérés comme expérimentés (ancienneté moyenne 3.2 ans).